Aspirin to Prevent Heart Attack and Stroke: What’s the Right Dose?
Open Access
- 1 March 2006
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 119 (3) , 198-202
- https://doi.org/10.1016/j.amjmed.2005.11.013
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≥70BMJ, 2005
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenNew England Journal of Medicine, 2005
- Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trialsAmerican Journal of Hematology, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT studyJournal Of Hypertension, 2000
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983